| Description | Cudarolimab (IBI101) is a fully human monoclonal antibody targeting OX40 (CD134), a costimulatory molecule expressed by activated immune cells. By inhibiting the interaction between OX40 and its ligand OX40L, Cudarolimab demonstrates antitumor activity, making it relevant for cancer research [1]. |
| molecular weight | N/A |
| CAS | 2244739-29-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |